AIM-Harvard/TrialPanorama-filtered huggingface dataset:
Trial: 3882071
Drug: No infusion
FDA approved: no
EMA approved: no
PMDA approved: no
Description: No infusion of contrast material
Trial: 3882071
Drug: Infusion of
RxNorm normalized name: OIL OF CAMPHOR
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Infusion of contrast material in high-risk group
Trial: 3882071
Drug: No infusion
FDA approved: no
EMA approved: no
PMDA approved: no
Description: No infusion of contrast material in high-risk group
Trial: 30353444
Drug: Ticagrelor 180
RxNorm normalized name: Ticagrelor
DrugBank: Ticagrelor (DB08816)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Ticagrelor 180 mg + Morphine
Trial: 28183002
Drug: TSB-based phototherapy
FDA approved: no
EMA approved: no
PMDA approved: no
Description: TSB-based phototherapy treatment
Trial: 23320487
Drug: oral atypical
FDA approved: no
EMA approved: no
PMDA approved: no
Description: oral atypical antipsychotic medication
Trial: 15545855
Drug: 4 doses
RxNorm normalized name: parathyroid hormone 25 MCG/Dose Cartridge, 14 Doses
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 4 doses of Pn‐PD at 2, 4, 6 and 12‐15 months
Trial: 15545855
Drug: 3 doses
RxNorm normalized name: ethinyl estradiol
DrugBank: Ethinylestradiol (DB00977)
FDA approved: yes
EMA approved: no
PMDA approved: yes
Description: 3 doses of Pn‐PD at 2, 4 and 6 months and 1 dose of 23‐valent polysaccharide vaccine (PncPS) at 12‐15 months
Trial: 15545855
Drug: 3 doses
RxNorm normalized name: ethinyl estradiol
DrugBank: Ethinylestradiol (DB00977)
FDA approved: yes
EMA approved: no
PMDA approved: yes
Description: 3 doses of hepatitis B vaccine at 2, 4 and 6 months and Pn‐PD at 12‐15 months
Trial: 10770194
Drug: Metyrapone administration
RxNorm normalized name: Metyrapone
DrugBank: Metyrapone (DB01011)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Metyrapone administration in normal men; n = 8
Trial: 10770194
Drug: Replacement therapy
RxNorm normalized name: Monistat Simple Therapy
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Replacement therapy in patients with chronic hypocortisolism; n = 8
Trial: 9327779
Drug: Atorvastatin 10
RxNorm normalized name: atorvastatin 10 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Atorvastatin 10 mg QD for 12 weeks increasing to 20 mg QD for 12 weeks
Trial: 9327779
Drug: Fenofibrate 100
RxNorm normalized name: fenofibrate 100 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Fenofibrate 100 mg TID for 24 weeks
Trial: 26888908
Drug: Ertapenem (1.0
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Ertapenem (1.0 g once daily)
Trial: 26888908
Drug: Piperacillin/tazobactam (4.5
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Piperacillin/tazobactam (4.5 g every 8 h)
Trial: 22770792
Drug: 10‐mL 1%
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 10‐mL 1% lidocaine paracervical block
Trial: 16219143
Drug: Combination (TCM
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Combination (TCM plus NP regimen)
Trial: 7832387
Drug: Recombinant human
RxNorm normalized name: Recombinant human TNF
DrugBank: Etanercept (DB00005)
FDA approved: yes
EMA approved: yes
PMDA approved: yes
Description: Recombinant human erythropoietin (RHE) at a loading dose of 300 U/kg iv 3 times/week for 1 week followed by 150 U/kg 3 times/week (N = 13) or 100 U/kg 3 times/week (N = 7)
Trial: 1977080
Drug: Low-dose zidovudine
RxNorm normalized name: ethinyl estradiol
DrugBank: Ethinylestradiol (DB00977)
FDA approved: yes
EMA approved: no
PMDA approved: yes
Description: Low-dose zidovudine (300 mg daily)
Trial: 1977080
Drug: Medium-dose zidovudine
RxNorm normalized name: Zidovudine
DrugBank: Zidovudine (DB00495)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Medium-dose zidovudine (600 mg daily)
Trial: 1977080
Drug: High-dose zidovudine
FDA approved: no
EMA approved: no
PMDA approved: no
Description: High-dose zidovudine (1500 mg daily)
Trial: 1977080
Drug: Acyclovir (4.8
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Acyclovir (4.8 g) with zidovudine
Trial: 1977080
Drug: All doses
RxNorm normalized name: All Clear
DrugBank: Ethanol (DB00898)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: All doses of zidovudine (300 mg, 600 mg, 1500 mg)
Trial: 344850
Drug: Theophylline 125
RxNorm normalized name: theophylline 125 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Theophylline 125 mg
Trial: 344850
Drug: Ephedrine SO4
RxNorm normalized name: EPHEDRINE SO4 25MG CAP
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Ephedrine SO4 30 mg
Trial: 26686385
Drug: hIL1bQb vaccine
RxNorm normalized name: Pertussis vaccine
DrugBank: Pertussis vaccine (DB15274)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: hIL1bQb vaccine (900 µg, six injections)
Trial: 26686385
Drug: hIL1bQb vaccine
RxNorm normalized name: Pertussis vaccine
DrugBank: Pertussis vaccine (DB15274)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: hIL1bQb vaccine
Trial: 23039299
Drug: Magnesium (10
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Magnesium (10 mmol bolus, 5 mmol/h infusion for 6 hours)
Trial: 17325559
Drug: Alanyl-glutamine (AG)
RxNorm normalized name: Alanyl glutamine
DrugBank: Alanyl glutamine (DB11876)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Alanyl-glutamine (AG) 24 g/d for 10 days
Trial: 17325559
Drug: Glycine (G)
RxNorm normalized name: Glycine
DrugBank: Glycine (DB00145)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Glycine (G) 25 g/d for 10 days (control)
Trial: 16562417
Drug: Individual TLFB
RxNorm normalized name: chloroxylenol
DrugBank: Chloroxylenol (DB11121)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Individual TLFB administration
Trial: 16562417
Drug: Group TLFB
RxNorm normalized name: Streptococcus viridans group
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Group TLFB administration
Trial: 12196420
Drug: Purified t10c12
RxNorm normalized name: Purified oxgall
DrugBank: Ox bile extract (DB14016)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Purified t10c12 CLA (3.4 g/day)
Trial: 12196420
Drug: CLA mixture
RxNorm normalized name: brown mixture
FDA approved: no
EMA approved: no
PMDA approved: no
Description: CLA mixture (3.4 g/day)
Trial: 7572573
Drug: Various predictors
RxNorm normalized name: various
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Various predictors including thrombolysis, coronary artery bypass grafting, diuretic use, heart rate, calcium channel blocker use, QRS duration
Trial: 2692821
Drug: Betamethasone dipropionate
RxNorm normalized name: Betamethasone Dipropionate
DrugBank: Betamethasone (DB00443)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Betamethasone dipropionate 0.05% cream, augmented formulation (AF), once-daily application
Trial: 2692821
Drug: Fluocinonide 0.05%
RxNorm normalized name: FLUOCINONIDE 0.05% OINT
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Fluocinonide 0.05% cream, twice-daily application
Trial: 57451
Drug: 1 alpha‐hydroxycholecalciferol
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 1 alpha‐hydroxycholecalciferol (1alpha‐H.C.C.) 1 mug daily for eleven weeks
Trial: 31859682
Drug: Clinically meaningful
RxNorm normalized name: DuoCare Clinical
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Clinically meaningful use (combination of learning, goal setting, and self-tracking)
Trial: 23874586
Drug: External beam
RxNorm normalized name: Beam
DrugBank: Tricyclazole (DB02891)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: External beam radiation in 10 fractions of 3 Gy, 5 fractions a week for 2 consecutive weeks with oral capecitabine 700 mg/m² twice daily throughout radiation therapy
Trial: 15558087
Drug: Manual toothbrush
RxNorm normalized name: sodium fluoride
DrugBank: Sodium fluoride (DB09325)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Manual toothbrush and chlorhexidine gluconate (CHX) spray (Group MC)
Trial: 15558087
Drug: Electrically powered
RxNorm normalized name: guaifenesin
DrugBank: Guaifenesin (DB00874)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Electrically powered toothbrush and CHX spray (Group EC)
Trial: 15558087
Drug: Chlorhexidine gluconate
RxNorm normalized name: Chlorhexidine Gluconate
DrugBank: Chlorhexidine (DB00878)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Chlorhexidine gluconate (CHX) spray (Group C)
Trial: 10529323
Drug: Unfractionated heparin
RxNorm normalized name: Unfractionated heparin
DrugBank: Heparin (DB01109)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Unfractionated heparin group
Trial: 7768249
Drug: Somatostatin (IV
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Somatostatin (IV loading dose 125 micrograms, followed by IV infusion of 125 micrograms.h‐1)
Trial: 7419830
Drug: Lodoxamide tromethamine
RxNorm normalized name: Lodoxamide Tromethamine
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Lodoxamide tromethamine (0.01 mg)
Trial: 7419830
Drug: Lodoxamide tromethamine
RxNorm normalized name: Lodoxamide Tromethamine
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Lodoxamide tromethamine (0.1 mg)
Trial: 7419830
Drug: Lodoxamide tromethamine
RxNorm normalized name: Lodoxamide Tromethamine
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Lodoxamide tromethamine (1.0 mg)
Trial: 18806833
Drug: G‐CSF+EPO
FDA approved: no
EMA approved: no
PMDA approved: no
Description: G‐CSF+EPO
Trial: 15090958
Drug: Albumin (25
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Albumin (25 g of a 25% solution every 8 hrs for a total of nine doses)
Trial: 15090958
Drug: Placebo (normal
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Placebo (normal saline administered in identical fashion and volume)
Trial: 15090958
Drug: Albumin treatment
RxNorm normalized name: Albumin Aggregated
DrugBank: Albumin Aggregated (DB14230)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Albumin treatment group
Trial: 7531868
Drug: Bisacodyl suppositories
RxNorm normalized name: Bisacodyl Suppositories
DrugBank: Bisacodyl (DB09020)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Bisacodyl suppositories
Trial: 27490086
Drug: Diabetes-specific preparation
RxNorm normalized name: Pacific oyster preparation
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Diabetes-specific preparation protocol (DSP)
Trial: 27490086
Drug: Conventional bowel
RxNorm normalized name: ascorbic acid
DrugBank: Ascorbic acid (DB00126)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Conventional bowel preparation protocol (CBP)
Trial: 24796059
Drug: Combined therapy
RxNorm normalized name: REGN10933+REGN10987 combination therapy
DrugBank: Anti-SARS-CoV-2 REGN-COV2 (DB15691)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Combined therapy (sword-like needle + chiropractic spinal manipulation)
Trial: 20526718
Drug: Intravenous amoxicillin
RxNorm normalized name: Amoxicillin
DrugBank: Amoxicillin (DB01060)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Intravenous amoxicillin plus clavulanic acid 1 g every 8 h followed by oral antibiotic after improvement and discharge the next day.
Trial: 20526718
Drug: Intravenous amoxicillin
RxNorm normalized name: Amoxicillin
DrugBank: Amoxicillin (DB01060)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Intravenous amoxicillin plus clavulanic acid for 7 days followed by oral antibiotic at discharge.
Trial: 19127910
Drug: Acupuncture plus
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Acupuncture plus medication (routine western medicine)
Trial: 19127910
Drug: Medication (routine
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Medication (routine western medicine)
Trial: 16721316
Drug: Short course
RxNorm normalized name: short ragweed pollen extract Sublingual Tablet [Ragwitek]
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Short course of family-based therapy (FBT)
Trial: 16721316
Drug: Long course
RxNorm normalized name: long pepper extract
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Long course of family-based therapy (FBT)
Trial: 1459173
Drug: n‐3 polyunsaturated
FDA approved: no
EMA approved: no
PMDA approved: no
Description: n‐3 polyunsaturated fatty acids (n‐3 PUFA) supplementation (3.6 g, 12 weeks)
Trial: 1459173
Drug: Placebo (six
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Placebo (six capsules with fat composition as the average Danish diet)
Trial: 31400177
Drug: Qualitative research
RxNorm normalized name: clotrimazole
DrugBank: Clotrimazole (DB00257)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Qualitative research alongside RCTs focusing on illicit drug use
Trial: 24951468
Drug: Health-related quality
RxNorm normalized name: Healthy Mama
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Health-related quality of life scores between children who received intravenous immunoglobulin and those who were carefully observed
Trial: 22150819
Drug: Twice weekly
RxNorm normalized name: Alora 0.1 MG/Day Twice Weekly Transdermal System
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Twice weekly supervision
Trial: 22150819
Drug: Daily supervision
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Daily supervision
Trial: 17268413
Drug: Flaxseed oil
RxNorm normalized name: Flaxseed Oil
DrugBank: Linseed oil (DB11357)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Flaxseed oil (8 g/day)
Trial: 17268413
Drug: Safflower oil
RxNorm normalized name: Safflower Oil
DrugBank: Safflower oil (DB09446)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Safflower oil (11 g/day linoleic acid)
Trial: 15703464
Drug: Clopidogrel 75
RxNorm normalized name: clopidogrel 75 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Clopidogrel 75 mg + acetylsalicylic acid (ASA) 75 mg daily
Trial: 15703464
Drug: ASA 75
RxNorm normalized name: ASA 75 MG Oral Tablet
FDA approved: no
EMA approved: no
PMDA approved: no
Description: ASA 75 mg/day
Trial: 15703464
Drug: Extended-release dipyridamole
RxNorm normalized name: ASPIRIN 25 mg / DIPYRIDAMOLE 200 mg ORAL CAPSULE, EXTENDED RELEASE [ASPIRIN AND EXTENDED-RELEASE DIPYRIDAMOLE]
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Extended-release dipyridamole 200 mg/low‐dose ASA 25 mg twice daily
Trial: 12075263
Drug: Medical therapy
RxNorm normalized name: Monistat Simple Therapy
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Medical therapy (MED(TMR) and MED(PTMR))
Trial: 2539838
Drug: Supplements containing
RxNorm normalized name: fish oil (containing omega-3 acids) Injection [Omegaven]
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Supplements containing DHA
Trial: 18116
Drug: Oral bucolome
RxNorm normalized name: CHICORY LEAF 15.4 g in 100 g ORAL LIQUID [BULOME S]
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Oral bucolome (30 mg/kg per day for 5 days)
Trial: 18116
Drug: Oral bucolome
RxNorm normalized name: CHICORY LEAF 15.4 g in 100 g ORAL LIQUID [BULOME S]
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Oral bucolome
Trial: 31112406
Drug: 15 g
RxNorm normalized name: 15 g/31 g
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 15 g of milk protein concentrate (MPC80) with 1.5 g of free leucine (15G+LEU)
Trial: 31112406
Drug: 15 g
RxNorm normalized name: 15 g/31 g
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 15 g of milk protein concentrate (MPC80) without leucine (15G)
Trial: 19377494
Drug: Pharmacological therapies
RxNorm normalized name: Theraplex Eczema Therapy
DrugBank: Colloidal oatmeal (DB11286)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Pharmacological therapies
Trial: 18007083
Drug: Traditional tidal
RxNorm normalized name: sodium fluoride
DrugBank: Sodium fluoride (DB09325)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Traditional tidal volume ventilation (10 mL/kg)
Trial: 14670310
Drug: Adult-type dTpa
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Adult-type dTpa booster vaccine (Boostrix)
Trial: 2680678
Drug: Controlled release
RxNorm normalized name: EpiCeram Controlled Release Skin Barrier Emulsion
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Controlled release salbutamol 8 mg twice daily
Trial: 2680678
Drug: Aminophylline 525
RxNorm normalized name: Aminophylline
DrugBank: Aminophylline (DB01223)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Aminophylline 525 or 700 mg twice daily
Trial: 31201653
Drug: Brief cognitive
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Brief cognitive behavioral therapy (bCBT) with physical health module
Trial: 20733446
Drug: Daily text-message
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Daily text-message reminders
Trial: 1955620
Drug: Diet with
RxNorm normalized name: Primatene with ephedrine Pill
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Diet with 30% calories from fat, 300 mg cholesterol/day
Trial: 1955620
Drug: Diet with
RxNorm normalized name: Primatene with ephedrine Pill
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Diet with 26% calories from fat, 200 mg cholesterol/day
Trial: 1955620
Drug: Diet with
RxNorm normalized name: Primatene with ephedrine Pill
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Diet with 22% calories from fat, 100 mg cholesterol/day
Trial: 1955620
Drug: Diet with
RxNorm normalized name: Primatene with ephedrine Pill
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Diet with 18% calories from fat, 100 mg cholesterol/day
Trial: 30127596
Drug: Milnacipran 100
RxNorm normalized name: milnacipran 100 mg oral tablet
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Milnacipran 100 mg
Trial: 24596459
Drug: IND +
RxNorm normalized name: up4 PROBIOTICS Mind + Body 2 Billion CFU Gummies (Very Berry)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: IND + GLY (indacaterol 150 μg and glycopyrronium 50 μg daily)
Trial: 24596459
Drug: IND +
RxNorm normalized name: up4 PROBIOTICS Mind + Body 2 Billion CFU Gummies (Very Berry)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: IND + PBO (indacaterol 150 μg daily and placebo)
Trial: 18066133
Drug: NG440 (a
FDA approved: no
EMA approved: no
PMDA approved: no
Description: NG440 (a combination of rho iso-alpha acids from hops, rosemary, and oleanolic acid)
Trial: 10210394
Drug: 2 mg
RxNorm normalized name: iodine 2 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 2 mg tolterodine
Trial: 10210394
Drug: 1 mg
RxNorm normalized name: biotin 1 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 1 mg tolterodine
Trial: 7790604
Drug: Inhaled nitric
RxNorm normalized name: nitric oxide Inhalant Product
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Inhaled nitric oxide (NO) at 18 ppm
Trial: 7790604
Drug: Infusion of
RxNorm normalized name: OIL OF CAMPHOR
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Infusion of prostacyclin (PGI2) at 4 ng.kg-1.min-1
Trial: 22368874
Drug: Reduning injection
RxNorm normalized name: Iron, reduced
DrugBank: Iron (DB01592)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Reduning injection plus antibiotics and basic therapy
Trial: 19650964
Drug: Nutrition education
RxNorm normalized name: Ocean Blue Nutritionals Omega-3 1450 Pill
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Nutrition education intervention in kindergartens (monthly activities for children and parents)
Trial: 31925809
Drug: Statin therapy
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Statin therapy (STA trial)
Trial: 20304051
Drug: Vitamin D
RxNorm normalized name: Vitamin D
DrugBank: Vitamin D (DB11094)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Vitamin D supplementation (4000 IU vitamin D3 daily for 6 months)
Trial: 11828240
Drug: 8 g
RxNorm normalized name: Theranost 68 Ga Rgd
DrugBank: NODAGA-THERANOST Ga-68 (DB16940)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 8 g NH(4)Cl acute administration
Trial: 7751874
Drug: 5-FU plus
RxNorm normalized name: 5-FU
DrugBank: Fluorouracil (DB00544)
FDA approved: yes
EMA approved: no
PMDA approved: yes
Description: 5-FU plus IFN (10 MU subcutaneously three times weekly)
Trial: 7751874
Drug: 5-FU alone
RxNorm normalized name: 5-FU
DrugBank: Fluorouracil (DB00544)
FDA approved: yes
EMA approved: no
PMDA approved: yes
Description: 5-FU alone (750 mg/m2/d by continuous infusion for 5 consecutive days followed by weekly bolus 5-FU 750 mg/m2)
Trial: 2281582
Drug: 75 ml
RxNorm normalized name: ethanol 0.75 ML/ML
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 75 ml of ioversol (Optiray-320)
Trial: 2281582
Drug: 100 ml
RxNorm normalized name: PVC IV Bag 100 mL
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 100 ml of diatrizoate (Renografin-60)
Trial: 382393
Drug: Meptazinol 100
RxNorm normalized name: meptazinol 100 MG/ML
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Meptazinol 100 mg intramuscularly
Trial: 382393
Drug: Omnopon 20
RxNorm normalized name: Omnopon 20 MG/ML Injectable Solution
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Omnopon 20 mg intramuscularly
Trial: 31723037
Drug: Heat-stable microparticle
RxNorm normalized name: (9-L-TYROSINE)HEAT-STABLE ENTEROTOXIN (ESCHERICHIA COLI)-(6-19)-PEPTIDE
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Heat-stable microparticle platform for oral micronutrient delivery (BMC)
Trial: 31723037
Drug: Initial human
RxNorm normalized name: Insulin Human
DrugBank: Insulin human (DB00030)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Initial human study of iron bioavailability from microparticles
Trial: 29429177
Drug: Planned neck
RxNorm normalized name: Plan B One-Step
DrugBank: Levonorgestrel (DB00367)
FDA approved: yes
EMA approved: no
PMDA approved: yes
Description: Planned neck dissection (PND) + concurrent chemoradiotherapy (CCRT)
Trial: 23852695
Drug: Tanezumab 10
RxNorm normalized name: tanezumab
DrugBank: Tanezumab (DB12335)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Tanezumab 10 mg + Diclofenac Sustained Release (DSR) 75 mg
Trial: 23852695
Drug: Tanezumab 5
RxNorm normalized name: tanezumab
DrugBank: Tanezumab (DB12335)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Tanezumab 5 mg + Diclofenac Sustained Release (DSR) 75 mg
Trial: 23852695
Drug: Tanezumab 2.5
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Tanezumab 2.5 mg + Diclofenac Sustained Release (DSR) 75 mg
Trial: 23852695
Drug: Placebo +
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Placebo + Diclofenac Sustained Release (DSR) 75 mg
Trial: 20137768
Drug: Test tablets
RxNorm normalized name: mumps skin test antigen
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Test tablets (Gen‐Nifedipine extended release)
Trial: 20137768
Drug: Reference tablets
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Reference tablets (Adalat XL)
Trial: 30218764
Drug: Prospective screening
RxNorm normalized name: SUN PROTECTANTS/SCREENS,TOPICAL
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Prospective screening program for C. difficile prior to cystectomy with prophylactic treatment using metronidazole.
Trial: 28179024
Drug: 4-monthly albendazole
RxNorm normalized name: Albendazole
DrugBank: Albendazole (DB00518)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: 4-monthly albendazole treatment